Atlas Trials

Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs

Clinical trial NCT00491725 · COMPLETED

Trial details

NCT number
NCT00491725
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2005-09-01
Primary completion
2006-06-01
Enrollment
187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.